Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends in survival of Danish AIDS patients from 1981 to 1989.
Pedersen C, Gerstoft J, Tauris P, Lundgren JD, Gøtzsche PC, Buhl M, Salim Y, Schmidt K, Nielsen JO. Pedersen C, et al. Among authors: buhl m. AIDS. 1990 Nov;4(11):1111-6. doi: 10.1097/00002030-199011000-00009. AIDS. 1990. PMID: 1980821
Zidovudine treatment of AIDS and ARC in Denmark 1987.
Teglbjaerg LL, Mathiesen LR, Søeberg B, Nielsen L, Thorsen B, Buhl M, Pedersen C, Bonnevie O, Nielsen C, Vestergaard BF, et al. Teglbjaerg LL, et al. Among authors: buhl m. Scand J Infect Dis. 1989;21(4):367-73. doi: 10.3109/00365548909167439. Scand J Infect Dis. 1989. PMID: 2685984 Clinical Trial.
Hepatitis C treatment response kinetics and impact of baseline predictors.
Lindh M, Arnholm B, Eilard A, Färkkilä M, Hellstrand K, Lagging M, Langeland N, Mørch K, Nilsson S, Pedersen C, Buhl MR, Wahlberg T, Wejstål R, Westin J, Norkrans G. Lindh M, et al. Among authors: buhl mr. J Viral Hepat. 2011 Jun;18(6):400-7. doi: 10.1111/j.1365-2893.2010.01323.x. J Viral Hepat. 2011. PMID: 20500548
Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection.
Pedersen C, Alsiö Å, Lagging M, Langeland N, Färkkilä M, Buhl MR, Mørch K, Westin J, Sangfelt P, Norkrans G, Christensen PB; NORDynamicIC Study Group. Pedersen C, et al. Among authors: buhl mr. J Viral Hepat. 2011 Apr;18(4):245-51. doi: 10.1111/j.1365-2893.2010.01303.x. J Viral Hepat. 2011. PMID: 20384961 Clinical Trial.
Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3.
Alsiö Å, Rembeck K, Askarieh G, Christensen PB, Färkkilä M, Langeland N, Buhl MR, Pedersen C, Mørch K, Haagmans BL, Nasic S, Westin J, Hellstrand K, Norkrans G, Lagging M. Alsiö Å, et al. Among authors: buhl mr. PLoS One. 2012;7(5):e37521. doi: 10.1371/journal.pone.0037521. Epub 2012 May 24. PLoS One. 2012. PMID: 22655053 Free PMC article. Clinical Trial.
367 results